Proximity ligation depends on proximal binding by pairs of detection reagents to generate amplifiable DNA strands, which then serve as surrogate markers for the detected protein molecules (1, 2 ) . The recently developed in situ proximity ligation assay (PLA) 5 can be used to image protein-protein interactions and posttranslational modifications in cells and tissues (3, 4 ) . Proximity probes consist of antibodies covalently linked to oligonucleotides, forming templates for circularization of 2 additional oligonucleotides. Circularization and ligation require coincident binding by the 2 proximity probes, thereby increasing selectivity compared with conventional assays that depend on binding by single reagents. Next, one of the antibody-bound oligonucleotides serves as a primer for rolling-circle amplification (RCA) (5 ) of the circular DNA molecule, anchoring the amplification product at the site of target recognition. RCA produces a single-stranded rolling-circle product (RCP) molecule, which consists of approximately 1000 complements of the DNA circle after a 1-h replication reaction with 29 DNA polymerase (6 ) . Individual RCPs are then visualized via hybridization of complementary fluorescently labeled oligonucleotides that reveal the locations of the detected proteins as spots of bright fluorescence.
One of the major challenges for detecting fluorescent probes in tissue samples is the prominent autofluores-cence that occurs in many tissues (7 ) . This autofluorescence can be caused by substances, such as the fluorescent pigments lipofuscin (8 ) and elastin, that contain fluorophores, one of which is a cross-linking tricarboxylic amino acid with a pyridinium ring (9 ) . This fluorophore is similar to that found in collagen, which also contributes to autofluorescence. Blood contamination of the tissue sample also produces strong autofluorescence, which is caused by the fluorescing heme molecule. Autofluorescence can also be caused by the fixative that is used. All these sources of autofluorescence compromise the use of fluorescence microscopy. Many techniques for reducing autofluorescence by chemical means have been described in the literature. CuSO 4 in ammonium acetate buffer, Sudan black B in 700 mL/L ethanol (10 ), NaBH 4 (11 ) , and pontamine sky blue (12 ) are some examples. It is also possible to use mathematical models to reduce autofluorescence by exploiting its broader excitation spectrum compared with the spectra of fluorescent labels (13, 14 ) . Additionally, 2-photon excitation and time-resolved fluorescence can be used to diminish or eliminate autofluorescence (15 ) . In a simpler and more straightforward alternative, the problem of autofluorescence can be avoided altogether by basing detection on enzymatic development of a substrate and visualizing the locations of the reaction products with bright-field microscopy.
Immunohistochemical methods have been used for decades to visualize specific antigens in tissues (16 ) . Staining with antibodies labeled with enzymes such as horseradish peroxidase (HRP) or alkaline phosphatase, a routine practice in pathology, allows visualization of specific proteins in tissues and cellular compartments. Standard tissue staining with hematoxylin and eosin allows simultaneous observation of the tissue histopathology. Fluorescence staining is used extensively because it is a very powerful analytic tool compared with bright-field microscopy and because it allows monitoring of several antigens in parallel; however, enzymelinked detection methods and bright-field microscopy remain more commonly used in clinical settings because of their simplicity and widespread adoption.
In the original publications describing in situ PLA (3, 4 ) , proteins were detected with fluorescence. In this report, we describe the coupling of in situ PLA with enzymatic visualization of RCPs to image the distribution of proteins or protein complexes in cells and tissues. HRP is conjugated to oligonucleotides in the same way that fluorescent molecules are conjugated for a fluorescence-based readout. We use the PLA to detect endogenous Smad2, a downstream effector of the transforming growth factor ␤ (TGF-␤) signaling pathway. Smad2 is translocated from the cytoplasm to the nucleus when cells are stimulated with TGF-␤. We used this molecule as a model to establish optimal conditions for detecting RCPs with HRP and 3,3Ј-diaminobenzidine tetrahydrochloride (DAB) staining. Furthermore, to demonstrate the correspondence of the results, we visualized estrogen receptor (ER), estradiol, and ER-estradiol complexes in breast cancer tissue by in situ PLA coupled to detection with either HRP or fluorescence. The 2 methods were also used to detect human epidermal growth factor receptor 2 (HER2) proteins in healthy skin. In this study we present a combination of in situ PLA, a highly sensitive and specific protein-detection method, which is also capable of visualizing protein complexes and protein modifications, with a bright-field readout. As brightfield microscopy is extensively and most prominently used in routine histopathology, we present examples in which we combine the detection of protein complexes and protein modifications with the ability to quantify the detection events with digital image-analysis software.
Materials and Methods

CELL CULTURE
Mouse embryonic fibroblasts (MEFs) were cultured in high-glucose DMEM (Sigma-Aldrich) supplemented with 100 g/L BSA and 1ϫ penicillin/streptomycin mix (all from Sigma-Aldrich) in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. For experiments, MEFs were seeded 16 h before treatment at approximately 10 000 cells/well in collagen-coated 8-well chamber slides (Nalge Nunc International). MEFs were then incubated with 5 mol/L of the low molecular weight inhibitor GW6604 (Roche) for 2 h. After washing in PBS (137 mmol/L NaCl, 10 mmol/L phosphate, 2.7 mmol/L KCl, pH 7.4), MEFs were either stimulated or not with 10 g/mL TGF-␤ (BioSource/ Invitrogen) in DMEM for 45 min. After treatment, MEFs were fixed with ice-cold 30 g/L paraformaldehyde (Sigma-Aldrich) in PBS for 15 min at room temperature. After fixation, the MEFs were washed twice for 5 min with PBS and permeabilized for 10 min with 5 mL/L Triton X-100 (Sigma-Aldrich) in PBS. The slides were then washed twice for 5 min with PBS to remove residual Triton X-100.
TISSUE PREPARATION
Breast tissue samples from patients with ER scores of 0 and 12, as established by regular histopathologic examination, were fixed in PBS-buffered 10% formalin (10% solution of a saturated formaldehyde solution) and embedded in paraffin according to standard pathology laboratory protocols. Four-micrometer sections were cut and placed onto positively charged slides (BDH Laboratory Supplies), incubated for 1 h at 60°C, dewaxed with a routine xylene-based (Histolab) deparaffinization method, and rehydrated in running tap water for 15 min. The slides were then incubated at 125°C at high pressure in a pressure cooker (Biocare Medical) in 600 mL citric acid/EDTA antigen-retrieval buffer (10 mmol/L citric acid, 2 mmol/L EDTA, and 0.5 mL/L Tween 20, pH 6.2; all reagents from SigmaAldrich) for 3 min. This procedure was followed by a 15-min wash in tap water.
IMMUNOCYTOCHEMISTRY
Tissue samples were incubated with 15 mL/L hydrogen peroxide in PBS for 15 min, followed by 2 short washes in H 2 O and then blocking in 50 g/L BSA in PBS for 30 min at room temperature to eliminate endogenous peroxidase activity and to minimize nonspecific binding. The ER was detected with a rabbit antihuman ER antibody (SP1; Abcam). Estradiol was detected with a mouse primary antiestradiol antibody (B42; Santa Cruz Biotechnology). The tissue sample was incubated with the antibodies (diluted to 1 part in 49 with 10 g/L BSA in PBS) for 1 h at room temperature and with constant agitation. The tissue samples were then washed 3 times for 5 min each in PBS. HRP-labeled polymers conjugated to goat antirabbit and antimouse immunoglobulins [EnVision™ϩ System-HRP (DAB) kit; Dako] were used as secondary binders. For detection, DAB staining mix, composed of 49 parts of DABϩ SUBSTRATE BUFFER and 1 part of DABϩ CHROMOGEN [EnVisionϩ System-HRP (DAB) kit], was used according to the procedure outlined by the manufacturer. In addition, routine staining with hematoxylin and eosin (both from Histolab) was performed. After dehydration and mounting with Depex (Electron Microscopy Sciences), the slides were examined with the aid of a Leica DMRE microscope equipped with a Leica 63ϫ/1.32-0.6 oil objective; images were acquired with a Leica DFC320 digital camera.
PLA PROTOCOL
The PLA assay was performed essentially as previously described (3, 17 ) with the HRP/NovaRed detection kit from Olink Bioscience, as follows: The paraformaldehyde-fixed cells and antigen-retrieved tissue were washed with PBS, incubated for 15 min in 15 mL/L hydrogen peroxide in PBS, washed, and blocked with blocking solution (1 part of 5ϫ Blocking stock in 4 parts high-quality water; Olink Bioscience). Primary antibodies (as described below) were applied, PLUS and MINUS secondary PLA probes against rabbit immunoglobulins only or against both rabbit and mouse immunoglobulins (Olink Bioscience) diluted in 1ϫ Antibody Diluent (1 part of 5ϫ Antibody Diluent stock in 4 parts high-quality water; Olink Bioscience) were added, and the cells and tissue were incubated overnight at 4°C with gentle agitation. The incubation was followed by 5-min washes in 3 changes of Trisbuffered saline with Tween (TBS-T) (0.05 mol/L Tris base, 9 g/L NaCl, pH 8.4, with 0.5 mL/L Tween 20). The hybridization solution (1 part of 5ϫ Hybridization stock in 4 parts high-quality water; Olink Bioscience) was incubated over the slides for 15 min, and the slides were washed once in TBS-T for 1 min. The slides were incubated with the ligation mix (8 parts of 5ϫ Ligation stock and 1 part of Ligase in 31 parts high-quality water; Olink Bioscience) for 30 min and then washed with 2 changes of TBS-T for 1 min each. The amplification mix (16 parts of 5ϫ Amplification stock and 1 part of Polymerase in 63 parts high-quality water; Olink Bioscience) was then applied to the slides for 90 min; the slides were then washed 5 times for 5 min each with TBS-T.
FLUORESCENCE DETECTION OF PLA REACTION PRODUCTS
The single-stranded RCA products were hybridized to fluorescently labeled probes by incubation with the detection solution (1 part of 5ϫ Detection stock 613 (component of the Duolink detection kit 613) in 4 parts high-quality water; Olink Bioscience) containing oligonucleotide probes conjugated to Texas Red. The RCA products were then washed for 5 min and counterstained with Hoechst 33342 (Sigma-Aldrich). After mounting with SlowFade medium (Invitrogen), we examined the slides with a Zeiss AxioPlan2 microscope equipped with a PlanNEOF Zeiss 63ϫ/1.32-0.6 oil objective. Images were acquired with an AxioCam MRm camera (Zeiss) equipped with filters optimized for detection of Texas Red and Hoechst 33342. Tissue sections that were to be rehybridized were first stripped of the fluorescently labeled detection oligonucleotide by 2 incubations 5 min each at 67°C with a glycerol-based mounting medium. Each incubation was followed by two 5-min washes with 700 mL/L ethanol and 1 wash with TBS.
DETECTION OF PLA REACTION PRODUCTS BY BRIGHT-FIELD
MICROSCOPY
The single-stranded RCA products were visualized with an HRP-labeled hybridization probe (5Ј-CAG TGA ATG CGA GTC CGT CT-3Ј; biomers.net) in standard saline citrate buffer (150 mmol/L NaCl, 15 mL sodium citrate) containing 0.5 mL/L Tween 20, 0.4 g/L BSA, and 0.01 g/L polyadenine (Sigma-Aldrich). After 1 wash with TBS for 2 min at room temperature, the sections were incubated with DAB staining mix (see Immunocytochemistry for information on) for 1 min and immediately washed with water. Hematoxylin and eosin counterstaining was used to visualize cellular structures. After serial dehydration and mounting with Depex, the slides were examined with the aid of a Leica DMRE microscope equipped with a Leica 63ϫ/1.32-0.6 oil objective; images were acquired with a Leica DFC320 camera.
ANTIBODY COMBINATIONS USED DURING IN SITU PLA
Rabbit monoclonal anti-Smad2 antibody (Epitomics) diluted to 1 part in 49 with 1ϫ Antibody Diluent (see PLA Protocol for information on) was used to detect Smad2 protein in cells and embryonic tissue. Samples were incubated with the anti-Smad2 antibody for 90 min at 37°C and washed with PBS.
ER in human breast cancer tissue was detected with rabbit antihuman ER antibody SP1, and estradiol was detected with mouse antiestradiol antibody B42. The tissues were incubated with each antibody (diluted to 1 part in 49 with 10 g/L BSA in PBS), individually or in combination, for 1 h at room temperature with constant agitation. The tissue samples were then washed 3 times for 5 min in PBS.
HER2 was detected in healthy human skin samples with a rabbit antihuman HER2 antibody (Dako). Antibody [diluted to 1 part in 49 with 1ϫ Antibody Diluent (see PLA Protocol for information on)] was added to the tissue sample and incubated for 1 h at room temperature with constant agitation. Tissue samples were then washed 3 times for 5 min in PBS.
IMAGE ANALYSIS
Fluorescence microscopy signals were quantified with BlobFinder software (18 ) , a freely available imageanalysis tool for image cytometry. Cell nuclei and point-source fluorescence signals were defined and quantified by shape and fluorescence intensity according to the standard procedures for this software tool. Settings were kept constant within each experimental series. A new version of the BlobFinder software, BlobFinderBright, was developed for bright-field microscopy and detection of HRP-based signals. It is also available on the BlobFinder Web site (http://www. cb.uu.se/ϳamin/BlobFinder/). Bright-field data, in contrast to fluorescence data, merges all intensity information into a single RGB image. A combination of image intensity and hue is used to delineate individual nuclei. First, the image is transformed into the huesaturation-intensity space (19 ) , where color or hue information is decoupled from intensity. Pixels belonging to cell nuclei are separated from those belonging to other structures on the basis of their blue color by thresholding of the hue data. An additional threshold on intensity then separates nuclei from background pixels. Signals are first defined from the intensity image according to their shape with the same approach as that used for fluorescence data, only with inverting the intensity. There is also an option based on color that uses a threshold for the hue of the signals to remove any false signals. This step removes false point-source structures originating from the blue nuclear stain. For cells and samples of healthy skin tissue, the software was used to count RCPs on a per-cell level, and each signal was assigned either to a nucleus or to a cytoplasm, with cytoplasm defined as the region within a fixed radius from a nucleus.
Results
Enzyme-linked detection with chromogenic substrates in bright-field microscopy offers a valuable complement to fluorescence for in situ detection of proteins, because it requires less expensive instrumentation, is compatible with standard histologic stains, and is not hindered by autofluorescence. We therefore decided to develop and optimize a protocol for HRP-assisted in situ PLA detection, and we have compared the performance of the 2 methods for visualizing reaction products in assays of potential clinical relevance.
MEFs were treated (Fig. 1, A and B) or not (Fig. 1 , C and D) for 45 min with 10 g/L of TGF-␤. The MEFs were then fixed, and in situ PLA was performed with an antibody against Smad2. Binding of this antibody was demonstrated with pairs of proximity probes directed against rabbit immunoglobulin and equipped with the 2 oligonucleotides required for template ligation of DNA circles that could then be replicated by RCA. No signal was detected when the primary (anti-Smad2) antibody was omitted from the in situ PLA reactions (Fig. 1, E and F) . The predominantly cytoplasmic localization of Smad2 in the absence of the TGF-␤ ligand agreed with earlier observations (20 ) and was in accord with the current model for the responses of cells to stimulation by TGF-␤ (Fig. 1, C and D) . TGF-␤ stimulation increased the nuclear localization of the Smad2 protein (Fig. 1, A and B) , as has previously been described (21 ) . The experiment was performed by hybridizing either Texas Red-conjugated or HRPconjugated oligonucleotides to the RCP. Images obtained with an HRP-conjugated oligonucleotide (Fig. 1, A, C , and E) were similar to those obtained with Texas Red-conjugated oligonucleotides (Fig. 1, B , D, and F).
We next sought to detect the Smad2 protein in early (6.5 days after conception) mouse embryos (see Fig S1, A and B , in the online Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol56/issue1). At this stage, Smad2 is ubiquitously expressed in mouse embryos (22 ) . We first used in situ PLA with fluorescence detection to visualize Smad2 (see Fig. S1B in the online Data Supplement). Then, we stripped the fluorescently labeled oligonucleotides from the RCPs, rehybridized the same RCPs with HRP-conjugated oligonucleotides, and reacted them with the DAB substrate (see Fig. S1A in the online Data Supplement). The results demonstrate extensive overlap of the signals visualized with the 2 approaches, down to the individual RCPs.
We used BlobFinder software to quantify the signals and assign them to the cells' nuclei or to the cytoplasms (Fig. 2) . There was some increase in the background signals in the bright-field images ( Fig. 2A) compared with the fluorescence images (Fig. 2B ) in the negative controls in which the primary antibody had been omitted. Nevertheless, the signals followed the known pattern of Smad protein distribution, with a 
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primarily cytoplasmic localization in the absence of TGF-␤ ligand and translocation of a substantial portion of the protein to the nucleus after TGF-␤ stimulation. It is notable that the patterns on the graphs for the 2 modes of visualization are highly similar (Fig. 2) .
OPTIMIZATION OF HRP DETECTION IN IN SITU PLA
Although assay conditions for fluorescence-based in situ PLA have been optimized (3, 4 ) , we were interested in establishing the optimal conditions for HRP readout. First, we decided to determine the optimal time for RCA (see Fig. S2A in the online Data Supplement). We performed rolling-circle replication for 10 min, 30 min, 90 min, and 360 min and observed that RCPs could hardly be detected after 30 min of RCA, whereas the signals were readily detectable after a 90-min reaction. A longer RCA time yielded larger complexes, but it also increased the assay time substantially. We therefore decided to use 90 min of RCA for the remaining experiments.
We next examined whether different times for hybridizing the HRP-conjugated oligonucleotide to the RCPs would affect RCP visualization (see Fig.  S2B in the online Data Supplement). RCPs could be detected within 15 min of hybridization, but RCP intensity and size were optimal with 30 min of hybridization. Longer hybridization times did not produce a further increase in RCP intensity or size but instead increased the background signal. We used 30 min of hybridization in all subsequent experiments.
To determine the optimal incubation time for visualizing RCPs with the DAB substrate, we incubated the DAB substrate from 20 s to 10 min (see Fig. S2C in the online Data Supplement). A 20-s incubation with the DAB substrate was sufficient to visualize RCPs. Longer incubation times failed to improve RCP visualization but increased the background staining. We used a 20-s incubation in all subsequent experiments with the DAB substrate.
DETECTION OF ER, ESTRADIOL, AND ER-ESTRADIOL INTERACTIONS BY IN SITU PLA IN BRIGHT FIELD
We next investigated the presence of ER, estradiol, and ER-estradiol complexes in human breast cancer tumors, which have previously been shown to be strongly positive or negative for ER production. First, we confirmed staining for estradiol and ER by regular immunohistochemical staining of tumors that had previously been shown to be negative (see Fig. S3 , A and C, in the online Data Supplement) and highly positive (see Fig. S3 , B and D, in the online Data Supplement) for ER status. We detected weak uniform staining for estradiol (Fig. S3 , A and C, in the online Data Supplement), whereas we observed ER staining only in the sample known to be highly positive (see Fig. S3D in the online Data Supplement). We then used in situ PLA to investigate the tumors for the presence of estradiol, ER, and the ER-estradiol complex. Estradiol was detected by in situ PLA in both ER-negative and ER-positive tissue sections (Fig. 3, A and B, respectively) . As expected, ER production was detected only in ERpositive tissue (Fig. 3D) . ER-estradiol complexes were detected only in ER-positive tissue. We observed that fluorescence images (Fig. 4) were very similar to those obtained in bright field with HRP-conjugated oligonucleotides.
After manually selecting representative tissue, we used BlobFinder software to quantify the signals. Fig. 5 shows the number of signals per sample area and tumor type as determined with BlobFinderBright software. The results obtained for the bright-field images (Fig. 5A) closely resemble those obtained with fluorescence (Fig. 5B) . The differences between the ERnegative and ER-positive tumors were significant (P Յ 0.03, t-tests) for estradiol detection and highly significant (P Յ 0.002, t-tests) for ER and ER-estradiol complex detection for both HRP-and fluorescence-based detection. These data show that fluorescence visualization and bright-field visualization yield equivalent results for in situ PLA RCA products. We can easily distinguish the positive tumor results from the negative tumor results independently of which of the 2 visualization approaches we use.
CORRELATION OF HER2 DETECTION IN BRIGHT FIELD AND BY
FLUORESCENCE
Additionally, we compared fluorescence and brightfield detection for in situ PLA of HER2 for a skin sample previously shown to be positive for the presence of HER2 (F. Hjelm, unpublished observations). We used 16 different areas of the tissue sample, half of which were randomly selected to be assayed with in situ PLA; the other half of the areas were assayed without HER2 primary antibody. We investigated 5 different regions for each tissue area and collected image data. We assayed for the presence of the HER2 protein by detecting the RCPs either with fluorescence or in the bright field after HRP detection. Fig. 6 , A-D, shows representative examples of the fluorescence images obtained. Fig. 6 , E-H, shows bright-field images of the same tissue samples. We measured the numbers of RCPs per cell by analyzing 200 -400 cells per image and found identical patterns of HER2 distribution with the 2 visualization methods (Fig. 6, I and K). Both the graphs and the original images (Fig. 6, B and F) show substantial cellto-cell variation with respect to the numbers of RCPs representing detected HER2 protein molecules, yet the variation data obtained with the 2 visualization methods are closely similar. This close correspondence is also obvious when the mean numbers of RCPs per cell per image field are plotted as a scatter plot (Fig. 6J) . These data again establish that the 2 visualization methods produce equivalent results and that enzyme-linked detection can accurately quantify proteins and protein complexes with regular bright-field microscopy.
Discussion
The ability to image proteins and their activated forms at cellular resolution is important for basic biological understanding and can provide valuable clinical insights for diagnostic and therapeutic purposes (23 ) . In situ PLA is a recently developed technology that permits, for the first time, endogenous protein interactions to be demonstrated directly in patients' tissue samples. The technology can contribute to basic knowledge in cell biology, but the method also has important implications for clinical diagnostics and prog-nostics by enabling highly specific analyses of the distribution of proteins in tissue samples and of functional markers, such as proteins, that actively interact in complexes or that undergo posttranslational modifications, such as phosphorylation, methylation, acetylation, and so on.
Immunohistochemistry is far more frequently used than fluorescence for routine in situ detection of proteins in histopathology, and it has advantages, such as less dependence on expensive instrumentation and the avoidance of autofluorescence problems, as well as compatibility with standard histologic stains. On the other hand, immunohistochemistry has some disadvantages, such as poor reproducibility and the difficulty of objectively quantifying the signals, which necessitates the use of complicated scoring systems (23 ) . Furthermore, signal quantification is primarily by visual means, which can lead to scoring bias by the observer. Additionally, immunohistochemistry, like regular fluorescence-assisted in situ detection of proteins, can assay only for the presence of individual proteins. In situ PLA, on the other hand, is a highly specific and sensitive method that can quantify the presence of proteins and protein complexes. It can also identify pro- tein modifications, such as phosphorylation, by devoting one antibody to detect the protein and the other to identify the phosphorylated site. With this work, we have developed a variant of the original in situ PLA that allows proteins and protein interactions to be evaluated with bright-field microscopy.
In situ PLA has clear advantages over immunohistochemistry with respect to signal quantification. Because the signals represent the quantification of single molecules, quantification becomes an issue of counting events rather than measuring intensity; consequently, quantification by counting makes automated image analysis far more robust. An increase in protein concentration produces an increase in the number of signals rather than an increased staining intensity. With BlobFinder (for fluorescence readout) or BlobFinderBright (for bright-field readout), signals can be counted in a fully automated manner, and large data sets can be batch-processed.
We have developed and applied a new protocol for visualizing in situ PLA signals for the study of proteins that fulfill different functions and that may reside in different intracellular locations. Smad2 is an intracellular effector and transcription factor that acts down- stream of TGF-␤ stimulation. ER is a nuclear receptor that requires binding to estradiol in order to bind to DNA and activate target gene transcription. HER2, finally, is a cell membrane-bound receptor tyrosine kinase involved in the signal-transduction pathways leading to cell growth and differentiation. With this range of molecules, we have illustrated the versatility of the method and the potential for clinical applications for detecting proteins and protein complexes. Image analysis enables quantification of the number of RCPs present and thus is a more objective way to categorize different specimens and tumor samples. The quality of automated signal quantification depends on the acquired image data. Fluorescence data are often easier to analyze because different fluorophores are imaged in separate imaging channels, making it possible to examine fluorescence signals without disturbance from, for example, a nuclear stain with a different fluorescence Box-and-whisker plots (minimum, maximum, 25th quartile, 75th quartile, median) of bright-field data (A) and fluorescence data (B) for the RCPs from the ER-negative and the ER-positive tumors are presented for the nuclear and cytoplasmic signals.
wavelength (assuming the data are not disturbed by autofluorescence). With bright-field data, all information is acquired in a single RGB image (e.g., a black stain is seen as zero intensity in all color channels). We have shown that by decoupling color and intensity information, we can separate blue cell nuclei from black or red signals and obtain a stable quantification of RCPs by bright-field microscopy. We do find more false signals, however, because many structures not seen in fluorescence microscopy can be misinterpreted as RCPs in the bright-field microscopy data. This phenomenon can be observed in the spreading of the whiskers in the Fig. 2 plots. This spreading is a byproduct of the nature of bright-field microscopy, in which all information is acquired in a single image that then requires computational analysis. On the other hand, bright-field microscopy offers better visualization of tissue morphology because, unlike fluorescence, it is compatible with hematoxylin and eosin staining.
In conclusion, HRP detection of PLA signals allows the superior ability of in situ PLA for characterizing proteins and protein complexes in cells and tissues to be applied to routine histopathology with brightfield microscopy.
